People with bipolar disorder who followed a ketogenic diet for at least six weeks found that their symptoms improved, a new ...

Q4 2024 Earnings Call Transcript March 4, 2025 NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.18, ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

Fourth Quarter 2024 Financial Results Total revenue in the fourth quarter of 2024 grew 19% to $21.5 million, compared with $18.0 million in the fourth quarter of 2023. The Company's revenue growth was ...

Joel Becker; President, Chief Executive Officer, Director; Neuropace Inc. Rebecca Kuhn; Chief Financial Officer ...

Health regulators in Canada gave conditionally approval to Qalsody to treat adults whose ALS is due to mutations in the SOD1 ...

This year, the Brain Prize, the most valuable research prize in the neurosciences and neuromedicine, worth more than one million euros, honors pioneering work on nervous system-cancer interactions: ...